Thank you.
On the other hand, we still don't understand what failed to work properly with the Canadian Access to Medicines Regime. In any event, there will definitely be other opportunities to look into this matter in greater depth at a later date.
My other question is for the Doctors Without Borders representatives. According to a report published by Doctors Without Borders on April 26, Canada ought to take a position in favour of exemptions from intellectual property agreements. For several weeks now, however, we've been hearing from others who disagree.
Mr. Joshua Tabah, the Director General, Health and Nutrition at the Department of Foreign Affairs, Trade and Development, said to us here on March 21 that the problem was not so much one of supply, but rather one of demand. It would appear that there were problems with getting available vaccines to developing countries. Perhaps Mr. Ferri would also like to comment on what Mr. Tabah said.
On April 25, we welcomed Mr. Seth Berkley, from the Gavi organization, which administers the COVAX initiative. He told us that even if patent restrictions were removed, it would not necessarily facilitate the decentralization of manufacturing to developing countries, because there would be a capacity problem, not only at the industry level, but also in terms of knowledge.
How do you react to these assessments stating that removing restrictions from intellectual property agreements would not necessarily solve any problems, because we are in a different phase now?